Erratum: Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy (Oncotarget (2018) 9 (5216-5232) DOI: 10.18632/oncotarget.23749)

Caroline M. Robb, Smit Kour, Jacob I. Contreras, Ekta Agarwal, Carter J. Barger, Sandeep Rana, Yogesh Sonawane, Beth K. Neilsen, Margaret Taylor, Smitha Kizhake, Rhishikesh N. Thakare, Sanjib Chowdhury, Jing Wang, Jennifer D. Black, Michael A. Hollingsworth, Michael G Brattain, Amarnath Natarajan

Research output: Contribution to journalComment/debatepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Erratum: Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy (Oncotarget (2018) 9 (5216-5232) DOI: 10.18632/oncotarget.23749)'. Together they form a unique fingerprint.

Medicine & Life Sciences